Your browser is no longer supported. Please, upgrade your browser.
MASI Masimo Corporation monthly Stock Chart
MASI [NASD]
Masimo Corporation
Index- P/E56.81 EPS (ttm)3.86 Insider Own0.70% Shs Outstand54.76M Perf Week-0.39%
Market Cap12.05B Forward P/E56.84 EPS next Y3.86 Insider Trans-69.04% Shs Float50.83M Perf Month-6.50%
Income222.20M PEG4.77 EPS next Q0.57 Inst Own85.30% Short Float1.82% Perf Quarter-6.07%
Sales1.05B P/S11.50 EPS this Y-1.00% Inst Trans1.04% Short Ratio1.43 Perf Half Y24.99%
Book/sh24.55 P/B8.93 EPS next Y21.33% ROA15.30% Target Price252.25 Perf Year46.56%
Cash/sh12.41 P/C17.66 EPS next 5Y11.90% ROE18.20% 52W Range139.36 - 258.00 Perf YTD38.71%
Dividend- P/FCF77.91 EPS past 5Y21.40% ROI15.70% 52W High-15.02% Beta0.88
Dividend %- Quick Ratio4.10 Sales past 5Y9.80% Gross Margin66.90% 52W Low57.32% ATR8.91
Employees1600 Current Ratio4.80 Sales Q/Q31.00% Oper. Margin23.30% RSI (14)43.72 Volatility4.08% 3.87%
OptionableYes Debt/Eq0.00 EPS Q/Q21.90% Profit Margin21.20% Rel Volume0.68 Prev Close225.10
ShortableYes LT Debt/Eq0.00 EarningsJul 28 AMC Payout0.00% Avg Volume647.08K Price219.24
Recom2.20 SMA20-4.66% SMA50-3.66% SMA20015.99% Volume444,530 Change-2.60%
Apr-20-20Downgrade Needham Buy → Hold
Mar-02-20Upgrade Raymond James Mkt Perform → Outperform $183
May-07-19Reiterated Needham Buy $155 → $158
Apr-16-19Downgrade BTIG Research Buy → Neutral
Mar-13-19Reiterated Needham Buy $148 → $155
Dec-19-18Upgrade Piper Jaffray Neutral → Overweight
Sep-14-18Initiated Needham Buy $139
Mar-09-18Initiated Barclays Overweight $97
Aug-14-17Upgrade BTIG Research Neutral → Buy $100
Apr-04-17Reiterated Wedbush Outperform $95 → $100
Mar-16-17Downgrade Piper Jaffray Overweight → Neutral
Feb-27-17Reiterated Wedbush Outperform $85 → $95
Feb-13-17Downgrade Raymond James Outperform → Mkt Perform
Aug-04-16Reiterated Wedbush Outperform $60 → $63
May-05-16Upgrade Piper Jaffray Neutral → Overweight
May-05-16Reiterated Wedbush Outperform $51 → $57
Jan-06-16Downgrade Raymond James Strong Buy → Outperform
Aug-05-15Reiterated ROTH Capital Buy $39 → $46
Jun-22-15Reiterated Wedbush Outperform $40 → $44
Jun-12-15Upgrade Raymond James Mkt Perform → Strong Buy $46
Aug-03-20 08:00AM  
Jul-31-20 01:26PM  
Jul-30-20 09:08AM  
Jul-29-20 07:42AM  
06:20AM  
Jul-28-20 11:31PM  
07:05PM  
04:55PM  
04:43PM  
04:05PM  
Jul-27-20 08:00AM  
Jul-21-20 12:31PM  
08:18AM  
Jul-20-20 04:44PM  
11:17AM  
02:00AM  
Jul-15-20 09:53AM  
Jul-14-20 09:00AM  
08:00AM  
Jul-13-20 10:53AM  
Jul-06-20 02:00AM  
Jul-01-20 08:35AM  
Jun-29-20 09:41AM  
08:00AM  
Jun-26-20 08:21AM  
Jun-25-20 04:49PM  
Jun-24-20 08:00AM  
Jun-22-20 07:43AM  
Jun-19-20 08:00AM  
08:00AM  
Jun-18-20 08:08AM  
Jun-16-20 01:33PM  
Jun-15-20 03:02PM  
Jun-09-20 09:47AM  
Jun-05-20 05:50PM  
09:34AM  
May-28-20 11:31AM  
May-27-20 08:00AM  
May-20-20 08:00PM  
May-18-20 11:11AM  
May-11-20 09:00AM  
May-08-20 11:32AM  
May-07-20 07:46AM  
May-06-20 09:48AM  
08:10AM  
May-04-20 02:00AM  
Apr-29-20 10:39AM  
08:14AM  
12:30AM  
Apr-28-20 05:28PM  
04:05PM  
10:08AM  
Apr-20-20 10:08AM  
09:09AM  
Apr-17-20 08:22PM  
09:32AM  
08:47AM  
Apr-16-20 06:09PM  
08:30AM  
Apr-15-20 12:00PM  
11:30AM  
Apr-14-20 09:38AM  
Apr-13-20 10:09AM  
09:42AM  
Apr-10-20 08:21AM  
06:00AM  
Apr-09-20 10:16AM  
08:00AM  
07:28AM  
07:26AM  
Apr-08-20 08:50AM  
Apr-07-20 08:00AM  
Apr-04-20 08:00AM  
Apr-03-20 08:30AM  
Apr-01-20 12:45PM  
10:53AM  
09:00AM  
Mar-30-20 11:30AM  
Mar-29-20 11:46AM  
Mar-25-20 06:20PM  
08:00AM  
Mar-24-20 09:51AM  
09:49AM  
12:12AM  
Mar-23-20 11:15PM  
08:00AM  
12:50AM  
Mar-20-20 11:30AM  
09:04AM  
07:44AM  
06:00AM  
Mar-19-20 04:01PM  
08:30AM  
Mar-16-20 11:03AM  
Mar-15-20 04:24PM  
Mar-14-20 08:00AM  
Mar-13-20 04:40PM  
10:03AM  
Mar-12-20 11:52AM  
11:30AM  
Masimo Corporation, a medical technology company, develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. In addition, the company offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; and O3 regional oximetry for tissue oxygen saturation measurement. Further, it provides Patient SafetyNet, a surveillance, remote monitoring, and clinician notification solution; MyView, a wireless presence-detection system; and connectivity devices. Additionally, the company offers Trace, a patient data visualization and reporting software for Masimo Root and Radical-7 monitors. The company provides its products directly, as well as through distributors and original equipment manufacturers partners to hospitals, emergency medical service providers, physician offices, home care providers, long term care facilities, veterinarians, and consumers. Masimo Corporation was founded in 1989 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Coleman JonPres-WW Sales,Pro Svc,Med AffsJul 06Option Exercise31.011,25038,76313,715Jul 08 04:05 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJul 06Sale235.001,250293,75012,465Jul 08 04:05 PM
Mikkelson AdamDirectorJun 08Sale216.011,498323,5832,802Jun 08 05:31 PM
Cohen H MichaelDirectorJun 04Sale225.37587132,292717Jun 08 05:05 PM
REYNOLDS CRAIG BDirectorMay 29Option Exercise240.191,304313,2084,300Jun 02 05:40 PM
Cohen H MichaelDirectorMay 29Option Exercise240.191,304313,2081,304Jun 02 05:36 PM
Shimer Julie AnnDirectorMay 29Option Exercise240.191,304313,2081,304Jun 02 05:33 PM
Mikkelson AdamDirectorMay 29Option Exercise240.191,304313,2084,300Jun 02 05:27 PM
Harkin ThomasDirectorMay 29Option Exercise240.191,304313,2087,685Jun 02 05:25 PM
Barker StevenDirectorMay 29Option Exercise240.191,304313,20867,549Jun 02 05:23 PM
FITCH SANFORDDirectorMay 29Option Exercise240.191,304313,20854,522Jun 02 05:21 PM
FITCH SANFORDDirectorApr 30Option Exercise21.9710,000219,70054,245May 04 04:06 PM
KIANI JOE ECEO and Chairman of the BoardApr 22Option Exercise21.9711,336249,052170,577Apr 24 04:05 PM
KIANI JOE ECEO and Chairman of the BoardApr 22Sale200.2711,3362,270,251159,241Apr 24 04:05 PM
KIANI JOE ECEO and Chairman of the BoardApr 17Option Exercise21.97111,4682,448,952270,709Apr 21 05:02 PM
KIANI JOE ECEO and Chairman of the BoardApr 17Sale200.70111,46822,371,706159,241Apr 21 05:02 PM
KIANI JOE ECEO and Chairman of the BoardApr 16Option Exercise21.97105,3182,313,836264,559Apr 16 04:57 PM
KIANI JOE ECEO and Chairman of the BoardApr 16Sale204.13105,31821,498,300159,241Apr 16 04:57 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsApr 15Option Exercise28.034,000112,12014,465Apr 15 07:12 PM
Young Micah WEVP & Chief Financial OfficerApr 15Option Exercise106.013,534374,6392,087Apr 15 07:14 PM
KIANI JOE ECEO and Chairman of the BoardApr 15Option Exercise21.7383,0861,805,449231,119Apr 16 04:57 PM
KIANI JOE ECEO and Chairman of the BoardApr 15Sale199.5883,08616,582,004159,241Apr 16 04:57 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsApr 15Sale197.504,000790,00012,465Apr 15 07:12 PM
Young Micah WEVP & Chief Financial OfficerApr 15Sale200.013,534706,8310Apr 15 07:14 PM
REYNOLDS CRAIG BDirectorApr 14Option Exercise23.049,752224,68612,748Apr 15 04:05 PM
Barker StevenDirectorApr 14Option Exercise41.8010,000418,00076,245Apr 15 04:25 PM
Lee YongsamEVP, CIOApr 14Option Exercise33.7410,000337,42081,000Apr 15 04:31 PM
Van Ramshorst David JSVP, Chief Accounting OfficerApr 14Option Exercise29.902,50074,7503,500Apr 15 04:27 PM
McClenahan Thomas SamuelEVP, GEN COUNSEL & CORP SECApr 14Option Exercise25.5410,000255,37013,264Apr 15 04:29 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsApr 14Option Exercise28.032,00056,06014,465Apr 15 07:12 PM
KIANI JOE ECEO and Chairman of the BoardApr 14Option Exercise20.19112,5782,272,950271,819Apr 16 04:57 PM
KIANI JOE ECEO and Chairman of the BoardApr 14Sale190.44112,57821,439,264159,241Apr 16 04:57 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsApr 14Sale190.002,000380,00012,465Apr 15 07:12 PM
Lee YongsamEVP, CIOApr 14Sale185.0110,0001,850,12575,000Apr 15 04:31 PM
Van Ramshorst David JSVP, Chief Accounting OfficerApr 14Sale191.002,500477,5001,000Apr 15 04:27 PM
Barker StevenDirectorApr 14Sale190.0010,0001,900,04566,245Apr 15 04:25 PM
McClenahan Thomas SamuelEVP, GEN COUNSEL & CORP SECApr 14Sale191.0110,0001,910,0636,264Apr 15 04:29 PM
REYNOLDS CRAIG BDirectorApr 14Sale184.009,7521,794,3682,996Apr 15 04:05 PM
REYNOLDS CRAIG BDirectorApr 13Option Exercise23.042485,7143,244Apr 15 04:05 PM
Sampath AnandEVP, Ops & Clinical ResearchApr 13Option Exercise21.7719,796430,95933,578Apr 15 04:15 PM
Lee YongsamEVP, CIOApr 13Option Exercise28.0310,000280,30085,000Apr 15 04:31 PM
Lee YongsamEVP, CIOApr 13Sale180.0010,0001,800,00075,000Apr 15 04:31 PM
Sampath AnandEVP, Ops & Clinical ResearchApr 13Sale180.0019,7963,563,28013,782Apr 15 04:15 PM
REYNOLDS CRAIG BDirectorApr 13Sale184.0024845,6322,996Apr 15 04:05 PM
KIANI JOE ECEO and Chairman of the BoardApr 09Option Exercise20.1951,9421,048,709211,183Apr 09 05:31 PM
KIANI JOE ECEO and Chairman of the BoardApr 09Sale185.5951,9429,639,885159,241Apr 09 05:31 PM
KIANI JOE ECEO and Chairman of the BoardApr 08Option Exercise20.1918,024363,905177,265Apr 09 05:31 PM
KIANI JOE ECEO and Chairman of the BoardApr 08Sale185.2718,0243,339,362159,241Apr 09 05:31 PM
KIANI JOE ECEO and Chairman of the BoardApr 07Option Exercise20.1928,716579,776187,957Apr 07 05:24 PM
Van Ramshorst David JSVP, Chief Accounting OfficerApr 06Option Exercise29.902,00059,8003,000Apr 07 04:25 PM
KIANI JOE ECEO and Chairman of the BoardApr 06Option Exercise20.1928,008565,482187,249Apr 07 05:24 PM
Muhsin BilalChief Operating OfficerApr 06Option Exercise30.857,000215,9305,000Apr 07 04:21 PM
Muhsin BilalChief Operating OfficerApr 06Sale184.007,0001,288,0000Apr 07 04:21 PM
KIANI JOE ECEO and Chairman of the BoardApr 06Sale185.3128,0085,190,081159,241Apr 07 05:24 PM
Van Ramshorst David JSVP, Chief Accounting OfficerApr 06Sale187.002,000374,0001,000Apr 07 04:25 PM
KIANI JOE ECEO and Chairman of the BoardApr 03Option Exercise20.197,439150,193166,680Apr 07 05:24 PM
KIANI JOE ECEO and Chairman of the BoardApr 03Sale185.5336,1556,707,749159,241Apr 07 05:24 PM
Van Ramshorst David JSVP, Chief Accounting OfficerMar 30Option Exercise37.841,50056,7602,500Mar 31 04:26 PM
Van Ramshorst David JSVP, Chief Accounting OfficerMar 30Sale183.001,500274,5001,000Mar 31 04:26 PM
Van Ramshorst David JSVP, Chief Accounting OfficerMar 27Option Exercise100.282,419242,5782,000Mar 31 04:26 PM
Van Ramshorst David JSVP, Chief Accounting OfficerMar 27Sale180.172,419435,8391,000Mar 31 04:26 PM
KIANI JOE ECEO and Chairman of the BoardMar 13Option Exercise20.1923,982484,197183,223Mar 16 06:58 PM
KIANI JOE ECEO and Chairman of the BoardMar 13Sale185.7623,9824,454,904159,241Mar 16 06:58 PM
KIANI JOE ECEO and Chairman of the BoardMar 12Option Exercise20.199,827198,407169,068Mar 16 06:58 PM
KIANI JOE ECEO and Chairman of the BoardMar 12Sale187.169,8271,839,228159,241Mar 16 06:58 PM
KIANI JOE ECEO and Chairman of the BoardMar 11Option Exercise29.36117,3633,446,248268,328Mar 12 05:23 PM
KIANI JOE ECEO and Chairman of the BoardMar 11Sale182.01117,36321,361,509159,241Mar 12 05:23 PM
KIANI JOE ECEO and Chairman of the BoardMar 10Option Exercise30.0650,5691,520,104209,810Mar 12 05:23 PM
KIANI JOE ECEO and Chairman of the BoardMar 10Sale181.0950,5699,157,555159,241Mar 12 05:23 PM
McClenahan Thomas SamuelEVP & General CounselFeb 06Option Exercise19.721,32326,0907,587Feb 06 05:16 PM
McClenahan Thomas SamuelEVP & General CounselFeb 06Sale176.041,323232,9016,264Feb 06 05:16 PM
McClenahan Thomas SamuelEVP & General CounselFeb 05Option Exercise19.727,477147,44613,741Feb 06 05:16 PM
McClenahan Thomas SamuelEVP & General CounselFeb 05Sale176.507,4771,319,7206,264Feb 06 05:16 PM
McClenahan Thomas SamuelEVP & General CounselFeb 04Option Exercise19.721,20023,6647,464Feb 06 05:16 PM
McClenahan Thomas SamuelEVP & General CounselFeb 04Sale176.011,200211,2126,264Feb 06 05:16 PM
Barker StevenDirectorJan 22Option Exercise28.0310,000280,30076,245Jan 24 04:04 PM
Barker StevenDirectorJan 22Sale175.0010,0001,750,00166,245Jan 24 04:04 PM
Young Micah WEVP & Chief Financial OfficerJan 17Option Exercise84.971,599135,8671,599Jan 17 08:27 PM
Young Micah WEVP & Chief Financial OfficerJan 17Sale170.061,599271,9320Jan 17 08:27 PM
Young Micah WEVP & Chief Financial OfficerJan 16Option Exercise84.978,401713,8338,401Jan 17 08:27 PM
Young Micah WEVP & Chief Financial OfficerJan 16Sale170.018,4011,428,2330Jan 17 08:27 PM
McClenahan Thomas SamuelEVP & General CounselJan 02Option Exercise0.002,00007,000Jan 06 04:10 PM
Lee YongsamEVP & CIOJan 02Option Exercise0.002,000075,000Jan 06 04:08 PM
Coleman JonPres-WW Sales,Pro Svc,Med AffsJan 02Option Exercise0.002,000013,201Jan 06 04:06 PM
Sampath AnandEVP, Ops & Clinical ResearchJan 02Option Exercise0.002,000014,518Jan 06 04:12 PM
KIANI JOE ECEO and Chairman of the BoardJan 02Option Exercise0.0020,0000159,241Jan 06 04:19 PM
McClenahan Thomas SamuelEVP & General CounselDec 20Option Exercise20.037,907158,35712,000Dec 20 07:40 PM
McClenahan Thomas SamuelEVP & General CounselDec 20Sale159.037,9071,257,4415,000Dec 20 07:40 PM
McClenahan Thomas SamuelEVP & General CounselDec 19Option Exercise22.4050011,2005,500Dec 19 08:50 PM
McClenahan Thomas SamuelEVP & General CounselDec 19Sale159.2950079,6445,000Dec 19 08:50 PM
McClenahan Thomas SamuelEVP & General CounselDec 18Option Exercise22.4098622,0865,986Dec 19 08:50 PM
McClenahan Thomas SamuelEVP & General CounselDec 18Sale159.00986156,7755,000Dec 19 08:50 PM
McClenahan Thomas SamuelEVP & General CounselDec 17Option Exercise22.4060713,5975,607Dec 19 08:50 PM
McClenahan Thomas SamuelEVP & General CounselDec 17Sale159.0060796,5135,000Dec 19 08:50 PM
Lee YongsamEVP & CIODec 16Option Exercise31.0124,000744,24097,000Dec 18 05:07 PM
Lee YongsamEVP & CIODec 16Sale156.8424,0003,764,08373,000Dec 18 05:07 PM
FITCH SANFORDDirectorDec 06Option Exercise41.807,000292,60051,245Dec 09 06:21 PM
FITCH SANFORDDirectorDec 06Sale156.277,0001,093,91344,245Dec 09 06:21 PM
Lee YongsamEVP & CIONov 20Option Exercise28.0310,675299,22083,675Nov 21 04:09 PM
Sampath AnandEVP, Ops & Clinical ResearchNov 20Option Exercise31.0115,000465,15027,518Nov 21 04:12 PM